Cytopenia

Disease1 paper

Humans1

Trial sponsors

Kirsten Grønbæk
1 trialPhase 240 people

Latest

10

HemaSphereHumans7 Oct

Blood-cell mutation patterns linked to cancer progression

A yearly rise of at least 7.5% in mutated gene copies’ share best predicted cancer progression among patients with unexplained low counts of certain…A yearly rise of at least 7.5% in mutated gene copies’ share best predicted cancer progression among patients with unexplained low counts of certain white blood cells.

LeukemiaHumans29 Sep

Clinical and molecular characteristics of clonal monocytosis with and without cytopenia(s)

Journal of Clinical MedicineResearch28 Sep

A Military Veteran with Pulmonary Fibrosis, Hepatic Cirrhosis, Bone Marrow Dysfunction and Shortened Telomeres Found to Have GAVE, a Potential Unsuspected Consequence of Telomere Spectrum Disorder

Telomerase and telomere maintenance

EJHaemResearch24 Sep

Reversible Eltrombopag-Associated Bone Marrow Fibrosis With Hematologic Recovery After Drug Withdrawal in ASXL1-Mutated Hypoplastic Myelodysplastic Syndrome: A Case Report

Myelodysplastic syndrome

CancerHuman trial21 Sep

Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo-controlled trial

CancerReview14 Sep

Clinical management of clonal hematopoiesis

Blood and immune system

European Journal of HaematologyHumans13 Sep

Serial VAF Kinetics Reveal Dynamic Clonal Evolution Associated With Progression in Clonal Cytopenia of Undetermined Significance

medRxivHumansPreprint2 Sep

Rare and Common Germline and Somatic Variants Shape Immune Cytopenia Risk and Enable Risk Stratification

LeukemiaHumans25 Aug

TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy

Clonal hematopoiesis of indeterminate potential

CureusResearch24 Aug

Chronic Neutrophilic Leukemia in a Patient With Multiple Myeloma